V
主页
京东 11.11 红包
Iron Stores in Nondialysis CKD Patients, with or without Anemia
发布人
-
打开封面
下载高清视频
观看高清视频
视频下载器
Dapagliflozin in Patients with Chronic Kidney Disease(2020/9)
达格列净对患有二型糖尿病患者肾脏疾病进展的影响:来自DECLARE-TIME58随机试验的分析
IL-6 and Cardiovascular Outcomes in Patients CKD and Chronic Coronary Syndrome
risk prediction models for ASCVD in patients with CKD:the CRIC Study
The spectrum of kidney biopsy findings in patients with morbid obesity
Apixaban versus warfarin in patients with atrial fibrillation and advanced CKD
B and T cell in patients with IMN may predict a response to rituximab
Race ,genetic ancestry,and estimating kidney function in CKD
Home-based aerobic exercise and resistance training for severe CKD
炎症性肠病和IgAN
BMI and risk of obesity-related complex multimorbidity
biomarkers of inflammation and repair in kidney disease progression
Effluent volume and dialysis dose in CRRT
肠道微生物产生的与蛋白质结合的尿毒素和代谢物在不同CKD分期未发生改变
DN中肌酐排泄率与死亡率的关系
AGEs predict loss of renal function and High-risk CKD in T2D.
血透患者肠道紊乱与死亡率的关系
2种免疫抑制剂对IgA的影响
肾功能中度损失的糖尿病患者肾小球滤过率的进行性下降
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes
the relationship between BP and risk of renal cell carcinoma
Metabolic Effects of Dapagliflozin with Type 1 Diabetes
DKK3 in Urine Identifies Patients with Short-Term Risk of eGFR Loss
肾小管损伤标志物与心血管疾病事件和死亡率的风险关系
Nomogram to predict the progression of patients with primary MN and NS
CKD和HC
Osteocalcin and risks of incident diabetes and DKD
IgAN强化支持治疗+免疫抑制治疗
Dapagliflozin in Patients with Chronic Kidney Disease
纵向研究高敏cTnT与CKD的死亡率关系
血浆biomarker 的浓度与糖肾进展的关系
直接肾素抑制剂在非糖尿病肾病患者中的作用
新诊断的糖尿病与非糖尿病患者肠道菌群的差异
Poly-IgA complexes and disease severity in IgAN
晚期CKD患者TMAO水平升高与心血管事件的增加有关
Noninvasive disgnosis of primary Membranous nephropathy using PLA2R antibodies
recurrent IgAN is predicted by altered Glycosylated IgA,auto antibodies and CD89
adolescent BP and the risk for early kidney damage in young adulthood
Glomerular Immunodeposits of IgAN Patients Are Enriched for IgG Auto-Ab
Canagliflozin and Renal Outcome in Type 2 Diabetes and Nephropathy(2019/4)